Michael Matthews (Jayco-AlUla) powered to his third victory in the Grand Prix de Québec, out-sprinting Biniam Girmay ...

The importance of skeletal muscle mass is increasingly being recognised in the medical field.1 The crucial roles of skeletal ...

WeightWatchers is remaking itself to appeal to both dieters and weight-loss medication users. But have consumers already lost ...

All results for Team Novo Nordisk from the last 10 days.

Novo Nordisk, tje manufacturer behind Ozempic and Wegovy has another weight loss medication in the works — but according to ...

Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker's experimental ...

Novo Nordisk's U.S.-listed shares lost ground Friday after a study of the pharmaceutical firm’s latest obesity treatment ...

The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.

Shares of Novo Nordisk NVO gained 4.2% on Sept. 11 after the company presented encouraging detailed efficacy data from the early-stage study of its new, investigational oral obesity pill ...

Shares were down 4.3% at 1330 GMT, the lowest since August 8, after the company announced headline results from its trial of ...

Novo Nordisk’s American depositary receipts tumbled almost 6% Friday after the drugmaker reported mixed results from a study of an experimental weight-loss pill. The pill, monlunabant, helped people ...